Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Biophysical Journal
|
August 9, 2005
Single-molecule spectroscopic determination of lac repressor-DNA loop conformation
Michael A Morgan, Kenji Okamoto, Jason D Kahn, et al.
Human Gene Therapy
|
August 16, 2024
Alpharetroviral Vector-Mediated Gene Therapy for IL7RA-Deficient Severe Combined Immunodeficiency
Teng-Cheong Ha, Michael A Morgan, Adrian J Thrasher, et al.
Stem Cells (Dayton, Ohio)
|
September 22, 2015
Letter to the Editor: Production of Mature Healthy Hematopoietic Cells from Induced Pluripotent Stem Cells Derived from an AML Diagnostic Sample Containing the t(8;21) Translocation
Dirk Hoffmann, Gudrun Göhring, Michael Heuser, et al.
Peerj
|
September 17, 2016
Whole gut microbiome composition of damselfish and cardinalfish before and after reef settlement
Darren J Parris, Rohan M Brooker, Michael A Morgan, et al.
British Journal of Haematology
|
September 15, 2005
Combining prenylation inhibitors causes synergistic cytotoxicity, apoptosis and disruption of RAS-to-MAP kinase signalling in multiple myeloma cells
Michael A Morgan, Tarkan Sebil, Erdem Aydilek, et al.
Optics Letters
|
November 18, 2011
Paraxial and nonparaxial polynomial beams and the analytic approach to propagation
Mark R Dennis, Jörg B Götte, Robert P King, et al.
World Journal of Urology
|
March 16, 2010
Carboplatin plus weekly docetaxel as salvage chemotherapy in docetaxel-resistant and castration-resistant prostate cancer
Christoph W M Reuter, Michael A Morgan, Philipp Ivanyi, et al.
Scientific Reports
|
August 13, 2021
Prognostic role of docetaxel-induced suppression of free testosterone serum levels in metastatic prostate cancer patients
Paula Kappler, Michael A Morgan, Philipp Ivanyi, et al.
Scientific Reports
|
June 20, 2025
Impact of adding carboplatin to docetaxel chemotherapy on testosterone levels and treatment outcomes in metastatic docetaxel-resistant prostate cancer
Hejar Atalan, Michael A Morgan, Philipp Ivanyi, et al.
World Journal of Urology
|
March 7, 2007
Targeting vascular endothelial growth factor (VEGF)-receptor-signaling in renal cell carcinoma
Christoph W M Reuter, Michael A Morgan, Viktor Grünwald, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Biophysical Journal
|
August 9, 2005
Single-molecule spectroscopic determination of lac repressor-DNA loop conformation
Michael A Morgan, Kenji Okamoto, Jason D Kahn, et al.
Human Gene Therapy
|
August 16, 2024
Alpharetroviral Vector-Mediated Gene Therapy for IL7RA-Deficient Severe Combined Immunodeficiency
Teng-Cheong Ha, Michael A Morgan, Adrian J Thrasher, et al.
Stem Cells (Dayton, Ohio)
|
September 22, 2015
Letter to the Editor: Production of Mature Healthy Hematopoietic Cells from Induced Pluripotent Stem Cells Derived from an AML Diagnostic Sample Containing the t(8;21) Translocation
Dirk Hoffmann, Gudrun Göhring, Michael Heuser, et al.
Peerj
|
September 17, 2016
Whole gut microbiome composition of damselfish and cardinalfish before and after reef settlement
Darren J Parris, Rohan M Brooker, Michael A Morgan, et al.
British Journal of Haematology
|
September 15, 2005
Combining prenylation inhibitors causes synergistic cytotoxicity, apoptosis and disruption of RAS-to-MAP kinase signalling in multiple myeloma cells
Michael A Morgan, Tarkan Sebil, Erdem Aydilek, et al.
Optics Letters
|
November 18, 2011
Paraxial and nonparaxial polynomial beams and the analytic approach to propagation
Mark R Dennis, Jörg B Götte, Robert P King, et al.
World Journal of Urology
|
March 16, 2010
Carboplatin plus weekly docetaxel as salvage chemotherapy in docetaxel-resistant and castration-resistant prostate cancer
Christoph W M Reuter, Michael A Morgan, Philipp Ivanyi, et al.
Scientific Reports
|
August 13, 2021
Prognostic role of docetaxel-induced suppression of free testosterone serum levels in metastatic prostate cancer patients
Paula Kappler, Michael A Morgan, Philipp Ivanyi, et al.
Scientific Reports
|
June 20, 2025
Impact of adding carboplatin to docetaxel chemotherapy on testosterone levels and treatment outcomes in metastatic docetaxel-resistant prostate cancer
Hejar Atalan, Michael A Morgan, Philipp Ivanyi, et al.
World Journal of Urology
|
March 7, 2007
Targeting vascular endothelial growth factor (VEGF)-receptor-signaling in renal cell carcinoma
Christoph W M Reuter, Michael A Morgan, Viktor Grünwald, et al.
Page
of 4